Yoshida H, Murakami T, Ogawa A, Sunouchi T, Hidaka N, Ito N
Endocrinol Diabetes Metab Case Rep. 2025; 2025(1).
PMID: 39868560
PMC: 11811822.
DOI: 10.1530/EDM-24-0121.
Tornero C, De Miguel E, Navarro-Compan V, Balsa A, Aguado P
JBMR Plus. 2024; 8(11):ziae124.
PMID: 39450343
PMC: 11499678.
DOI: 10.1093/jbmrpl/ziae124.
Kim S, Korkmaz F, Sims S, Ryu V, Yuen T, Zaidi M
Osteoporos Sarcopenia. 2024; 9(4):115-120.
PMID: 38374822
PMC: 10874721.
DOI: 10.1016/j.afos.2023.12.003.
Alsarraf F, Ali D, Almonaei K, Al-Alwani H, Khan A, Brandi M
Osteoporos Int. 2023; 35(4):717-725.
PMID: 37993691
DOI: 10.1007/s00198-023-06943-z.
Reis F, Lazaretti-Castro M
Arch Endocrinol Metab. 2023; 67(5):e000626.
PMID: 37249457
PMC: 10665056.
DOI: 10.20945/2359-3997000000626.
Biochemical and clinical manifestations in adults with hypophosphatasia: a national cross-sectional study.
Hepp N, Frederiksen A, Duno M, Jorgensen N, Jensen J
Osteoporos Int. 2022; 33(12):2595-2605.
PMID: 35986118
DOI: 10.1007/s00198-022-06536-2.
Gene Therapy Using Adeno-Associated Virus Serotype 8 Encoding TNAP-D Improves the Skeletal and Dentoalveolar Phenotypes in Alpl Mice.
Kinoshita Y, Mohamed F, de Oliveira F, Narisawa S, Miyake K, Foster B
J Bone Miner Res. 2021; 36(9):1835-1849.
PMID: 34076297
PMC: 8446309.
DOI: 10.1002/jbmr.4382.
[Prevalence of hypophosphatasia in adult patients in rheumatology].
Karakostas P, Dolscheid-Pommerich R, Hass M, Weber N, Brossart P, Schafer V
Z Rheumatol. 2021; 81(6):513-519.
PMID: 33852075
PMC: 9338116.
DOI: 10.1007/s00393-021-00994-5.
The Effect of Antler Deer Extracts from East Kalimantan in Bone Turnover Cell Models.
Widyowati R, Suciati S, Haryadi D, Chang H, Suryawan I, Utama A
Turk J Pharm Sci. 2020; 17(4):440-445.
PMID: 32939141
PMC: 7489350.
DOI: 10.4274/tjps.galenos.2019.57805.
Congenital Hyperphosphatemic Conditions Caused by the Deficient Activity of FGF23.
Ito N, Fukumoto S
Calcif Tissue Int. 2020; 108(1):104-115.
PMID: 31965220
DOI: 10.1007/s00223-020-00659-6.
Update on the management of hypophosphatasia.
Choida V, Bubbear J
Ther Adv Musculoskelet Dis. 2019; 11:1759720X19863997.
PMID: 31413732
PMC: 6676257.
DOI: 10.1177/1759720X19863997.
Hypophosphatasia: From Diagnosis to Treatment.
Simon S, Resch H, Klaushofer K, Roschger P, Zwerina J, Kocijan R
Curr Rheumatol Rep. 2018; 20(11):69.
PMID: 30203264
DOI: 10.1007/s11926-018-0778-5.
Healthcare resource utilization in the management of hypophosphatasia in three patients displaying a spectrum of manifestations.
Daniel A, Saraff V, Shaw N, Yates R, Mughal M, Padidela R
Orphanet J Rare Dis. 2018; 13(1):142.
PMID: 30115096
PMC: 6097329.
DOI: 10.1186/s13023-018-0869-4.
Mutational and biochemical findings in adults with persistent hypophosphatasemia.
McKiernan F, Dong J, Berg R, Scotty E, Mundt P, Larson L
Osteoporos Int. 2017; 28(8):2343-2348.
PMID: 28401263
DOI: 10.1007/s00198-017-4035-y.
Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment.
Whyte M
Nat Rev Endocrinol. 2016; 12(4):233-46.
PMID: 26893260
DOI: 10.1038/nrendo.2016.14.
Adult hypophosphatasia with painful periarticular calcification treated with surgical resection.
Iida K, Fukushi J, Fujiwara T, Oda Y, Iwamoto Y
J Bone Miner Metab. 2011; 30(6):722-5.
PMID: 22167380
DOI: 10.1007/s00774-011-0338-9.
Osteomalacia revisited : a report on 28 cases.
Gifre L, Peris P, Monegal A, Martinez de Osaba M, Alvarez L, Guanabens N
Clin Rheumatol. 2010; 30(5):639-45.
PMID: 20949298
DOI: 10.1007/s10067-010-1587-z.
[Osteoarthritis in hereditary metabolic diseases].
Zwerina J, Dallos T
Orthopade. 2010; 39(6):637-46.
PMID: 20559790
DOI: 10.1007/s00132-010-1646-9.
Whole-body MRI in the childhood form of hypophosphatasia.
Beck C, Morbach H, Wirth C, Beer M, Girschick H
Rheumatol Int. 2010; 31(10):1315-20.
PMID: 20383509
DOI: 10.1007/s00296-010-1493-3.
[Osteoarthritis in hereditary metabolic diseases].
Zwerina J, Dallos T
Z Rheumatol. 2010; 69(3):227-35.
PMID: 20300760
DOI: 10.1007/s00393-009-0590-8.